Moderna and Merck release melanoma vaccine trial results

Statements (10 of 14)

1. ● Neutral

   Moderna and Merck are preparing to officially present detailed results of the cancer vaccine trial.

   jornaldenegocios.ptOct 23, 2026 20:47 UTC
2. ● Neutral

   Moderna's Phase 3 data for its cancer vaccine has raised questions about the need for the treatment.

   marketwatch.comOct 23, 2026 18:58 UTCHigh importance
3. ● Neutral

   A vaccine against cancer has shown promising results and could reach the market in 2027

   infomoney.com.brOct 23, 2026 17:00 UTC
4. ● Neutral

   Doctors call Moderna and Merck cancer vaccine data a major advancement for melanoma patients.

   cnbc.comOct 23, 2026 16:24 UTC
5. ▼ Bearish

   Merck and Moderna released full trial results for a melanoma vaccine made for their own tumors.

   gizmodo.comOct 23, 2026 13:45 UTC
6. ▲ Bullish

   Moderna presents promising data for its new cancer vaccine

   wiwo.deOct 23, 2026 10:54 UTC
7. ▲ Bullish

   Moderna and Merck reported that their mRNA cancer vaccine reduced death and recurrence by 42%.

   arstechnica.comOct 22, 2026 22:12 UTCHigh importance
8. ● Neutral

   Moderna and Merck released results of a major trial for a first-of-its-kind cancer vaccine.

   yahoo.comOct 22, 2026 21:39 UTCHigh importance
9. ● Neutral

   Moderna and Merck announced a significant result for their mRNA-based cancer vaccine developed in collaboration.

   portfolio.huOct 22, 2026 18:50 UTCHigh importance
10. ● Neutral

    Moderna is releasing trial results for its cancer vaccine.

    marketwatch.comOct 21, 2026 15:00 UTCHigh importance

4 more statements on this development this week. The API returns all of them: GET /v2/statements?topic_id=c0f87db8-485c-4a93-9d48-159f49d66841 Get a free API key ↗